Xenotransplantation and risk : regulating a developing biotechnology / Sara Fovargue.
2012
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS | |
Author
Title
Xenotransplantation and risk : regulating a developing biotechnology / Sara Fovargue.
Imprint
Cambridge, U.K. ; New York, N.Y. : Cambridge University Press, 2012.
Description
1 online resource (xiii, 291 pages).
Series
Cambridge law, medicine, and ethics.
Cambridge books online.
Cambridge books online.
Formatted Contents Note
Introducing the issues
Dealing with risk
Regulating experimental procedures and medical research
Regulatory responses to developing biotechnologies
Challenges to legal and ethical norms : first party consent and third parties at risk
Surveillance and monitoring : balancing public health and individual freedom
Summary and concluding thoughts : looking to the future.
Dealing with risk
Regulating experimental procedures and medical research
Regulatory responses to developing biotechnologies
Challenges to legal and ethical norms : first party consent and third parties at risk
Surveillance and monitoring : balancing public health and individual freedom
Summary and concluding thoughts : looking to the future.
Summary
"Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health"-- Provided by publisher.
Bibliography, etc. Note
Includes bibliographical references and index.
Source of Description
Description based on print version record.
Location
WWW
Available in Other Form
Print version: Fovargue, Sara, 1971- Xenotransplantation and risk. Cambridge ; New York : Cambridge University Press, 2012
Linked Resources
Language
English
ISBN
9781139223522 electronic book
1139223526 electronic book
9781139026925 electronic book
1139026925 electronic book
9780521195768
0521195764
9781139216999
1139223526 electronic book
9781139026925 electronic book
1139026925 electronic book
9780521195768
0521195764
9781139216999
Record Appears in